Mechanisms of action, efficacy, and safety of icosapent ethyl: from bench to bedside.
作者信息
Bhatt Deepak L
机构信息
Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
出版信息
Eur Heart J Suppl. 2020 Oct 6;22(Suppl J):J1-J2. doi: 10.1093/eurheartj/suaa114. eCollection 2020 Oct.
Abstract
摘要
相似文献
1
Mechanisms of action, efficacy, and safety of icosapent ethyl: from bench to bedside.二十碳五烯酸乙酯的作用机制、疗效及安全性：从实验室到临床应用
Eur Heart J Suppl. 2020 Oct 6;22(Suppl J):J1-J2. doi: 10.1093/eurheartj/suaa114. eCollection 2020 Oct.
2
Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides.依折麦布辛伐他汀乙酯可降低 3 期慢性肾脏病伴高甘油三酯血症且他汀类药物治疗高危患者的致动脉粥样硬化标志物。
Postgrad Med. 2019 Aug;131(6):390-396. doi: 10.1080/00325481.2019.1643633. Epub 2019 Jul 25.
3
Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis.依泽替米贝在他汀类药物治疗持续高甘油三酯血症的糖尿病女性患者中的血脂作用：ANCHOR 试验亚组分析。
J Womens Health (Larchmt). 2018 Sep;27(9):1170-1176. doi: 10.1089/jwh.2017.6757. Epub 2018 Mar 27.
4
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies.二十碳五烯酸乙酯：来自MARINE和ANCHOR研究的患者血浆载脂蛋白C-III水平的影响。
J Clin Lipidol. 2016 May-Jun;10(3):635-645.e1. doi: 10.1016/j.jacl.2016.02.008. Epub 2016 Feb 23.
5
Icosapent ethyl for treatment of elevated triglyceride levels.二十碳五烯酸乙酯治疗甘油三酯升高。
Ann Pharmacother. 2013 Nov;47(11):1517-23. doi: 10.1177/1060028013504079. Epub 2013 Nov 5.
6
Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Pharmacokinetic Parameters of Rosiglitazone in Healthy Subjects.二十碳五烯酸乙酯对健康受试者中罗格列酮药代动力学参数的影响。
Clin Pharmacol Drug Dev. 2015 Mar;4(2):143-148. doi: 10.1002/cpdd.150. Epub 2014 Dec 3.
7
Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study).依折麦布辛伐他汀对超高敏 C 反应蛋白患者致动脉粥样硬化脂质/脂蛋白、载脂蛋白和炎症参数的影响（来自 ANCHOR 研究）。
Am J Cardiol. 2019 Sep 1;124(5):696-701. doi: 10.1016/j.amjcard.2019.05.057. Epub 2019 Jun 6.
8
Icosapent ethyl: Eicosapentaenoic acid concentration and triglyceride-lowering effects across clinical studies.二十碳五烯酸乙酯：临床研究中的二十碳五烯酸浓度及降甘油三酯作用。
Prostaglandins Other Lipid Mediat. 2016 Sep;125:57-64. doi: 10.1016/j.prostaglandins.2016.07.007. Epub 2016 Jul 11.
9
The cost-effectiveness of icosapent ethyl in combination with statin therapy compared with statin alone for cardiovascular risk reduction.依折麦布辛伐他汀与他汀类药物联合治疗与他汀类药物单药治疗相比在降低心血管风险方面的成本效益。
Eur J Prev Cardiol. 2021 Jul 23;28(8):897-904. doi: 10.1177/2047487319896648. Epub 2020 Jan 10.
10
Effect of icosapent ethyl on susceptibility to ventricular arrhythmias in postinfarcted rat hearts: Role of GPR120-mediated connexin43 phosphorylation.依泽替米贝对心肌梗死后大鼠心室性心律失常易感性的影响：GPR120 介导的连接蛋白 43 磷酸化的作用。
J Cell Mol Med. 2020 Aug;24(16):9267-9279. doi: 10.1111/jcmm.15575. Epub 2020 Jul 8.
引用本文的文献
1
Preventive Therapies in Peripheral Arterial Disease.外周动脉疾病的预防性治疗
Biomedicines. 2023 Nov 27;11(12):3157. doi: 10.3390/biomedicines11123157.
2
Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATE.冠状动脉斑块形态的定量成像生物标志物：来自EVAPORATE研究的见解
Front Cardiovasc Med. 2023 Aug 3;10:1204071. doi: 10.3389/fcvm.2023.1204071. eCollection 2023.
3
Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements-A Narrative Review.降脂药物和补充剂的抗炎作用——一项叙述性综述
Nutrients. 2023 Mar 21;15(6):1517. doi: 10.3390/nu15061517.
4
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.依泽替米贝治疗经皮冠状动脉介入治疗后患者的缺血事件：来自 REDUCE-IT PCI 的见解。
J Am Heart Assoc. 2022 Mar 15;11(6):e022937. doi: 10.1161/JAHA.121.022937. Epub 2022 Mar 9.
本文引用的文献
1
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid.ω-3 脂肪酸二十碳五烯酸的心血管保护作用的新机制。
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1135-1147. doi: 10.1161/ATVBAHA.119.313286. Epub 2020 Mar 26.
2
Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics.依泽替米贝在 REDUCE-IT 试验中显著降低首发和全心血管事件：为何这些结果开创了血脂异常治疗的新时代。
Eur Heart J. 2020 Jun 21;41(24):2304-2312. doi: 10.1093/eurheartj/ehz778.
3
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT.依折麦布辛伐他汀对全因缺血事件的影响：来自 REDUCE-IT 研究。
J Am Coll Cardiol. 2019 Jun 11;73(22):2791-2802. doi: 10.1016/j.jacc.2019.02.032. Epub 2019 Mar 18.
4
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.依泽替米贝降低严重高甘油三酯血症患者心血管风险
N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.
Zotero 插件